![Heath Lukatch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Heath Lukatch
Direktor/Vorstandsmitglied bei
VAXCYTE, INC.
Vermögen: 922 261 $ am 31.01.2026
Profil
Heath Lukatch founded Automate Scientific, Inc. in 1992, where he worked as Chief Executive Officer from 1992 to 1996 and Red Tree Venture Capital in 2020, where he is working as Managing Partner from 2020.
Dr. Lukatch also currently works at Magnus Medical, Inc., as Chairman from 2021, Acrigen Biosciences, Inc., as Chairman from 2021, Engrail Therapeutics, Inc., as Director from 2024, and various other companies.
Dr. Lukatch also formerly worked at Virsti Therapeutics, Inc., as Chief Executive Officer & Director from 2021 to 2023, Cianna Medical, Inc., as Chairman from 2011 to 2015, Spinifex Pharmaceuticals Pty Ltd., as Chairman from 2014 to 2015, and various other companies.
Dr. Lukatch received his doctorate degree in 1997 from Stanford University and undergraduate degree in 1990 from the University of California, Berkeley.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VAXCYTE, INC. 0,01 % | 12.06.2025 | 17.216 ( 0,01 % ) | 922 261 $ | 31.01.2026 |
Aktive Positionen von Heath Lukatch
| Unternehmen | Position | Beginn |
|---|---|---|
| VAXCYTE, INC. | Direktor/Vorstandsmitglied | 01.05.2018 |
Red Tree Venture Capital
 Red Tree Venture Capital Red Tree Venture Capital seeks investment opportunities in companies located in the US. The firm targets companies operating in the fields of life science innovation sectors. It provides financing for early stage capital requirements. | Gründer | 01.03.2020 |
Acrigen Biosciences, Inc.
 Acrigen Biosciences, Inc. Operates as a biotechnology company | Vorsitzender | 01.07.2021 |
Excellergy, Inc.
 Excellergy, Inc. Provides therapeutic services for treatment of severe allergic diseases | Direktor/Vorstandsmitglied | - |
Engrail Therapeutics, Inc.
 Engrail Therapeutics, Inc. Develops and commercializes medicines for treating neuron diseases | Direktor/Vorstandsmitglied | 01.03.2024 |
Magnus Medical, Inc.
 Magnus Medical, Inc. Develops closed-loop neuro-modulation technology for mental health conditions | Vorsitzender | 01.12.2021 |
Viewpoint Therapeutics, Inc.
 Viewpoint Therapeutics, Inc. Provides drug discovery and development services for alpha-crystallin aggregation inhibitors as investigational non-surgical treatments | Direktor/Vorstandsmitglied | 05.03.2018 |
FLAP LLC
 FLAP LLC Provides licensing and royalty services for medicines | Direktor/Vorstandsmitglied | - |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures is an active manager which provides funding for early and later-stage capital requirements, and provides management support. The firm invests in both public and private companies from Northern Europe and the United States. Novo Ventures targets companies operating in the health technology and health services sector, and industries such as biotechnology and medical specialties. It looks to take minority stake positions in its investments, as well as a seat on the board. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Heath Lukatch
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Heath Lukatch
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
75
Beziehungen ersten Grades
47
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 47 |
|---|---|
Chiron Corp.
 Chiron Corp. Provides nucleic acid test for blood screening | |
Dynavax Technologies Corp.
 Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
Piper Sandler & Co. (Broker)
 Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Standard BioTools, Inc.
 Standard BioTools, Inc. Medical SpecialtiesHealth Technology Manufactures and markets innovative technologies and tools for life sciences research | Health Technology |
InSound Medical, Inc.
 InSound Medical, Inc. Medical SpecialtiesHealth Technology Develops and manufactures hearing devices | Health Technology |
Verax Biomedical, Inc.
 Verax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Develops rapid tests for detecting bacterial contaminants in blood cells and tissues | Commercial Services |
Inogen, Inc.
 Inogen, Inc. Medical SpecialtiesHealth Technology Operates as a medical technology company | Health Technology |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
FoldRx Pharmaceuticals LLC
 FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides drug discovery and clinical development services | Health Technology |
Amira Pharmaceuticals, Inc.
 Amira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
Alios BioPharma, Inc.
 Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Adynxx, Inc. (Old)
 Adynxx, Inc. (Old) Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
SI-BONE, Inc.
 SI-BONE, Inc. Operates as a sacroiliac joint medical device company | |
Halo Neuro, Inc.
 Halo Neuro, Inc. Develops neuroscience based technology | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Palo Alto LLC
 Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Discovers and develops medicines | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SightLine Partners LLC
 SightLine Partners LLC Investment ManagersFinance SightLine Partners invests in both public and private companies located in the United States. The firm focuses on medical technology, digital health, life science and healthcare service sectors. It provides financing for buyout and growth transactions. The firm makes follow-on investments. | Finance |
Cianna Medical, Inc.
 Cianna Medical, Inc. Medical SpecialtiesHealth Technology Provides treatment of early-stage breast cancer in women | Health Technology |
Elevation Pharmaceuticals, Inc.
 Elevation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures aerosol drug products | Health Technology |
Novo Ventures 1 A/S
Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures is an active manager which provides funding for early and later-stage capital requirements, and provides management support. The firm invests in both public and private companies from Northern Europe and the United States. Novo Ventures targets companies operating in the health technology and health services sector, and industries such as biotechnology and medical specialties. It looks to take minority stake positions in its investments, as well as a seat on the board. | Finance |
NeuroTherapeutics Pharma, Inc.
 NeuroTherapeutics Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical and therapeutic drugs for central nervous system disorders | Health Technology |
Spinifex Pharmaceuticals Pty Ltd.
 Spinifex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drug candidates for the treatment & management of pain | Health Technology |
Nora Therapeutics, Inc.
 Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments for infertility and miscarriages | Health Technology |
Synosia Therapeutics, Inc.
 Synosia Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops products for unmet medical needs in psychiatry and neurology | Health Technology |
Automate Scientific, Inc.
 Automate Scientific, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and distributes biomedical equipment | Health Technology |
FLAP LLC
FLAP LLC Provides licensing and royalty services for medicines | |
Panmira Pharmaceuticals LLC
 Panmira Pharmaceuticals LLC Provides drug development programs for inflammatory diseases | |
Novo Ventures (US), Inc.
 Novo Ventures (US), Inc. Novo Ventures US invests venture capital in biotechnology and life science companies throughout the US and Europe. Their typical investments are as equity ranging from 1 to 15 million Euro. The firm may invest at any stage of development of a business idea - from seed capital over private placements to IPOs and public companies and they may invest in any part of the world. | |
Viewpoint Therapeutics, Inc.
Viewpoint Therapeutics, Inc. Provides drug discovery and development services for alpha-crystallin aggregation inhibitors as investigational non-surgical treatments | |
Vaxcyte, Inc.
 Vaxcyte, Inc. Develops vaccines for infectious diseases | |
Lagunita Biosciences LLC
 Lagunita Biosciences LLC Lagunita Biosciences invests in companies located in the United States. It focuses on companies operating in the fields of ophthalmology, protein engineering, drug discovery, surgical devices and mobile health services. It participates in early stage transactions. | |
Satsuma Pharmaceuticals, Inc.
 Satsuma Pharmaceuticals, Inc. Operates as a biopharmaceutical company for migraine and debilitating conditions | |
TPG Biotech
 TPG Biotech TPG Biotech seeks investment opportunities in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, medical technology, and healthcare services. It provides financing for early and later stage capital requirements. | |
Engage Therapeutics, Inc.
 Engage Therapeutics, Inc. Develops rescue therapy for uncontrolled epileptic seizures | |
Ceribell, Inc.
 Ceribell, Inc. Develops electroencephalography medical device and related AI based platform | |
Acrigen Biosciences, Inc.
Acrigen Biosciences, Inc. Operates as a biotechnology company | |
Red Tree Venture Capital
Red Tree Venture Capital Red Tree Venture Capital seeks investment opportunities in companies located in the US. The firm targets companies operating in the fields of life science innovation sectors. It provides financing for early stage capital requirements. | |
Engrail Therapeutics, Inc.
Engrail Therapeutics, Inc. Develops and commercializes medicines for treating neuron diseases | |
Bicara Therapeutics, Inc.
 Bicara Therapeutics, Inc. Operates as a clinical-stage biopharmaceutical company that develops and sells therapeutics for tumors | |
Virsti Therapeutics, Inc. | |
Magnus Medical, Inc.
Magnus Medical, Inc. Develops closed-loop neuro-modulation technology for mental health conditions | |
Cargo Therapeutics, Inc.
 Cargo Therapeutics, Inc. Engages in generation of adoptive cell therapies for cancer treatment | |
Excellergy, Inc.
Excellergy, Inc. Provides therapeutic services for treatment of severe allergic diseases |
